Skip to main content

University of Missouri

News

Dr. Kathryn Moss poses by a microscope

Muscular Dystrophy Association Spotlights Dr. Kathryn Moss

Dr. Moss’s research on the pathogenesis of Charcot-Marie-Tooth disease Type 1A (CMT1A) and hereditary neuropathy with liability pressure palsies (HNPP) aims to identify and better understand the mechanisms behind these diseases – and ultimately, develop therapies to treat them.

Researchers Zachary Berndsen and Keith Cassidy stand outside the Roy Blunt NextGen Precision Health building.

A Protein at the Heart of Heart Disease

Mizzou researchers discover the structure of a protein that could lead to more targeted heart disease treatments.

Dr. Nathan Kerr and Dr. Frank Booth

Inactive Today, Forgetful Tomorrow

A new study shows specific changes in the brain after muscle disuse that are linked with cognitive decline.

Finger stick blood test for diabetes patient

Overactive Cells Linked to Type 2 Diabetes

Researchers from the University of Missouri are studying potential therapies to target specific cells linked to the development of cardiovascular and metabolic disorders like high blood pressure and type 2 diabetes.

We had three special guests share their own ALS stories. Tyler Brundige, left, is a School of Medicine alum who lost his brother Chase to ALS a year ago and helped fund the event. Mary Ellen Sobule, middle, lost her sister Kathleen to ALS. Finally, Renee White, right, is living with an ALS diagnosis. Hearing their powerful stories reaffirmed the need for a cure.

NextGen's Motor Neuron Symposium

A day dedicated to sharing insights and discoveries that will advance our understanding of motor neuron diseases, specifically amyotrophic lateral sclerosis, or ALS.

The EM Core team with University leadership at the Roy Blunt NextGen Precision Health Building.

State-of-the-art imaging in Mizzou’s Electron Microscopy Core

This suite of world-class electron microscopes allows Mizzou researchers to magnify and analyze materials at the highest possible resolution. Thanks to our partners at Thermo Fisher Scientific, the core now has even more powerful equipment that further expands our capabilities for discovery.

Esma Yolcu and Haval Shirwan together in the NextGen Precision Health courtyard.

MU Researchers Join Cancer Prevention Network

MU is one of four institutions nationwide to receive National Cancer Institute funding for research on activating the immune system against cancer.

Sophomore Brett Boney, photographed by Pate McCuien.

Student Success Story: Brett Boney

Boney conducts research in the lab of Bret Ulery, an associate professor in the College of Engineering and researcher with NextGen Precision Health. The lab focuses, in part, on analyzing novel polymer-based products to ultimately improve regenerative medicine.

Kathryn Moss with lab members

Brad's Bites: Kathryn Moss Interview

Dr. Kathryn Moss is studying a disease she's also been diagnosed with, CMT, at Mizzou. She joined us to discuss her research on the latest Brad's Bites.

Dr. David Arnold, Dr. Anthony Japour and Dr. Rick Barohn together before the event begins

NextGen's 'Beyond The Bench' Event

There are several career pathways involving more than academic research, including entrepreneurship and work in the biotech industry.

Elizabeth Parks, Scott Rector & Jamal Ibdah at the Roy Blunt NextGen Precision Health building.

New Study Shows Diet, Exercise Reverses Liver Damage

New research from the University of Missouri School of Medicine suggests intensive lifestyle interventions are an effective way of treating and improving liver disease.

The 7-Tesla MRI machine at NextGen Precision Health

Mizzou’s Techiest Tools

From virtual reality to robots, Tigers have access to the latest technology across campus. Check out 16 locations, tools and devices that will level up your college experience.

Abstract rendering of a human face with colorful shapes overlaid.

Corinna Singleman Chats with Smita Saxena

Smita Saxena, PhD, is a lifelong learner who has dedicated her life to unraveling the circuitry of the brain and the diseases tied up in it, like amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease (AD).

Hannah Gryder, 12, is prepared for a lung MRI

Changing Cystic Fibrosis Care, One Less Cough at a Time: Hannah’s Story

Coughing was just a fact of life for Hannah Gryder. For as long as her grandmother, Tina Wood, can remember, the rasping noise and chest spasms would disrupt Hannah’s sleep.

The Shirwan & Yolcu lab at NextGen Precision Health

Five Ways Mizzou is Helping Lead America’s Fight Against Cancer

Two researchers are joining a national cancer-fighting network in the latest example of Mizzou’s dedication to finding a cure.

Elderly Man Medical Breathing Apparatus

Sleep Apnea May Increase Risk of Abdominal Aortic Aneurysms

Obstructive sleep apnea may be a risk factor for developing abdominal aortic aneurysms, according to researchers from the University of Missouri School of Medicine and NextGen Precision Health.

Haval Shirwan in the lab

Haval Shirwan Named Curators' Distinguished Professor

The University of Missouri Board of Curators recently named nine University of Missouri faculty members Curators’ Distinguished Professors and one Curators' Distinguished Professor Emeritus.

Jack Cheng with a 3D depiction of a protein structure

Paving the Way for New Treatments

Mizzou researcher Jianlin “Jack” Cheng debuts tool to build 3D structure of protein complexes, giving scientists insights to prevent and treat disease.

Haval Shirwan in the wet lab

Immunologist Earns Global Transplantation Honor

Haval Shirwan, PhD, an inventor on 29 issued and nine pending patents and a co-founder of three biotech startups, is receiving a distinction from his global peers that is only bestowed every two years. The world’s premier association for transplantation science will honor Shirwan’s career working toward safe and effective immunomodulation.

Luis Martinez-Lemus, Camila Manrique and Jaume Padilla pose together

Clearing the Way for Healthy Arteries

A trio of researchers in Mizzou’s Roy Blunt NextGen Precision Health building have developed a treatment for a leading cause of heart disease in America.